Annual report pursuant to Section 13 and 15(d)

Segment Reporting (Tables)

v3.23.3
Segment Reporting (Tables)
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment The tables below present financial information for the Company’s two operating business segments.
Year Ended December 31,
2022 2021
(As Restated)
(As Restated)
Revenues:
Corporate clinics $ 59,422,294  $ 44,348,234 
Franchise operations 41,830,016  35,662,779 
Total revenues
 $ 101,252,310  $ 80,011,013 
Depreciation and amortization:
Corporate clinics $ 5,557,494  $ 3,279,603 
Franchise operations 744,172  334,945 
Corporate administration 344,956  307,339 
Total depreciation and amortization $ 6,646,622  $ 3,921,887 
Segment operating income:
Corporate clinics $ 110,257  $ 6,599,932 
Franchise operations 17,340,402  15,353,621 
Unallocated corporate (16,622,405) (15,827,588)
Total segment operating income $ 828,254  $ 6,125,965 
Reconciliation of total segment operating income to consolidated earnings before income taxes:
Total segment operating income $ 828,254  $ 6,125,965 
Other (expense), net (133,101) (69,878)
Income before income tax expense (benefit) $ 695,153  $ 6,056,087 
Schedule of Reconciliation of Assets from Segment to Consolidated
December 31, 2022 December 31, 2021
(As Restated)
(As Restated)
Segment assets:
Corporate clinics $ 56,008,234  $ 40,032,271 
Franchise operations 12,360,878  12,593,912 
Total segment assets $ 68,369,112  $ 52,626,183 
Unallocated cash and cash equivalents and restricted cash $ 10,550,417  $ 19,912,338 
Unallocated property and equipment 915,216  857,176 
Other unallocated assets 13,655,632  13,666,050 
Total assets $ 93,490,377  $ 87,061,747